Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Implementation of Teledermoscopy and Artificial Intelligence

NCT: NCT05033678 · RECRUITING

NCT IDNCT05033678
StatusRECRUITING
Start Date2021-08-16
Completion2029-08-31
SponsorRegion Skane (OTHER)
First posted
Last updated

Brief Summary

The study has 2 parts. Part 1 will investigate the effects of introducing teledermoscopy in clinical practice, more specifically the change in referral patterns, the risk of undetected skin cancers and the effect on diagnostic accuracy in general practitioners. Part 2 will create artificial intelligence (AI) as support tools for teledermocsopic assessors and investigate the effect of introducing AI within teledermocsopy. In this study the investigators will measure the diagnostic accuracy of teledermoscopic assessors that had access to the results of artificial intelligence algorithm compared to those who did not. Data will be collected through teledermoscopic referrals, patient records, national registries and questionnairs.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑